ArticlePediatric nephrology (Berlin, Germany)2018
Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease.
Article in Pediatric nephrology (Berlin, Germany), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 31 citations in OpenAlex.
- Microalbuminuria in children with cyanotic congenital heart disease in Enugu, Nigeria; a comparative study.BMC nephrology · 2025Article
- Article
- Kidney Transplantation in Congenital Heart Disease Patients: What Are the Outcomes?Pediatric transplantation · 2025Article
- Framework for Kidney Health Follow-Up Among Neonates With Critical Cardiac Disease: A Report From the Neonatal Kidney Health Consensus Workshop.Journal of the American Heart Association · 2025Review
- Overexpression of plasmalemmal vesicle-associated protein-1 in patient with cyanotic nephropathy: a case report.BMC nephrology · 2025Article
- Independent prognostic value of lipocalin-2 in congenital heart disease-associated pulmonary artery hypertension.World journal of cardiology · 2024Article
- Long-Term Renal Involvement in Association with Fontan Circulation.Pediatric cardiology · 2024Observational
- Case report: Challenging kidney transplantation in an adolescent patient with tetralogy of Fallot.Frontiers in medicine · 2024Article
- Activation of renal epithelial NaFrontiers in pediatrics · 2024Article
- Using Serum Cystatin C to Predict Acute Kidney Injury Following Infant Cardiac Surgery.Pediatric cardiology · 2023Observational
- Chronic kidney disease in patients with congenital heart disease: a nationwide, register-based cohort study.European heart journal open · 2022Article
- Persistent Markers of Kidney Injury in Children Who Developed Acute Kidney Injury After Pediatric Cardiac Surgery: A Prospective Cohort Study.Journal of the American Heart Association · 2022Article
- Incidence and risk factors for chronic kidney disease in patients with congenital heart disease.Pediatric nephrology (Berlin, Germany) · 2021Article
- Development of nephropathy in an adult patient after Fontan palliation for cyanotic congenital heart disease.CEN case reports · 2021Article
- Evaluation of neonatal acute kidney injury after critical congenital heart disease surgery.Pediatric nephrology (Berlin, Germany) · 2021Article
- Retinal microvasculature impairment in patients with congenital heart disease investigated by optical coherence tomography angiography.Clinical & experimental ophthalmology · 2020Article
- Increased Urine Albumin-to-Creatinine Ratio-a Harbinger of Renal Dysfunction after Repair of Congenital Heart Disease?Korean circulation journal · 2018Article
- Is it time for a multi-specialty approach to cardio-renal dysfunction in children with cyanotic congenital heart disease?Pediatric nephrology (Berlin, Germany) · 2018Article
- Effects of sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor, on renal impairment in patients with cyanotic congenital heart disease.Annals of pediatric cardiologyArticle
Corrections and comments
- Commented on by
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCyanotic nephropathy (CN), seen in 30-50% of patients with congenital cyanotic heart disease (CCHD), affects both tubular and glomerular function, resulting in proteinuria and azotemia. Microalbuminuria is an early marker for glomerular damage and an independent predictor of progressive renal disease.
methodsA cross-sectional study was conducted. A total of 116 patients aged 1 month to 15 years with CCHD at Chiang Mai University Hospital between 2015 and 2016 were assessed and 94 patients were enrolled. To determine the prevalence and associated factors of significant albuminuria in CCHD patients, baseline characteristics, oxygen saturation, surgery, hemoglobin (Hb), hematocrit (Hct), spot urine albumin, urine protein, and creatinine were obtained. Binary logistic-regression modeling was used to identify associated factors.
resultsPrevalence of CN in children with CCHD was 58.51% and 92.55% according to albuminuria and proteinuria staging respectively. Prevalence of significant proteinuria, significant albuminuria, and decreased GFR was 88.30%, 41.49% and 31.91% respectively. Participants with significant albuminuria had fewer previous surgeries (p = 0.05), a longer waiting time for surgery (p = 0.02), enalapril usage (p = 0.04), pulmonary hypertension (p = 0.03), higher Hct z-score (p = 0.03) and lower platelet count (p = 0.001) compared with those without significant albuminuria. Using multivariate logistic regression analysis, waiting duration for surgery (p = 0.04), Hct >40% (p = 0.02), and platelet count <290,000/mm
conclusionsCyanotic nephropathy can be detected in the first decade of life with the presentation of microalbuminuria. High Hct level and low platelet count were identified as a predictor of microalbuminuria, whereas early cardiac surgery decreased the risk of developing significant albuminuria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.